Female Urology Update Lynnetta Faith Payne, DO, FACOS Urological Surgeon

Total Page:16

File Type:pdf, Size:1020Kb

Female Urology Update Lynnetta Faith Payne, DO, FACOS Urological Surgeon Female Urology Update Lynnetta Faith Payne, DO, FACOS Urological Surgeon Objectives: -diagnosis -risk factors -treatment UTI Incontinence 64 year old woman presents with a 3 year history of recurrent urinary tract infections (UTIs) treated with multiple antibiotic courses by a walk-in clinic What are the clinical symptoms associated with UTI? Irritative symptoms Urgency Frequency Dysuria Hematuria Foul odor Suprapubic pain Upper tract infections (pyelonephritis) fevers rigors flank pain nausea and emesis Congested vasculatures and extensive lamina propria hemorrhage Can be accompanied by sloughing of surface urothelium, ulceration or cytologic atypia depending on the cause of hemorrhagic cystitis Patient reports presumed bladder infections which occur every month or two associated with dysuria, urgency, and frequency. No gross hematuria, flank pain, or fevers. What is the differential diagnosis? Many processes and conditions may mimic the symptoms of bacterial urinary tract infection, so it is critical to rule out other causes during the evaluation prior to initiating treatment. Urologic neoplasm Atrophic vaginitis Overactive bladder Trauma Congenital abnormalities Urethral diverticulum Sexually transmitted diseases – Herpes, Chlamydia, Trichomonas, Gonorrhea Urinary lithiasis Interstitial cystitis/painful bladder syndrome Sepsis from non-urologic source Interstitial cystitis Urethral diverticulum Renal atrophy Diagnosis of UTI Presentation of clinical symptoms Physical exam for atrophic vaginitis, urethral diverticulum etc Clean-catch midstream urine sample Chemical dipstick urinalysis Quantitative urine culture; In general > 100,000 colonies/ml diagnostic Dipstick urinalysis evaluation Leukocyte esterase 63-90% specific Nitrite very specific for gram negative but only 50% sensitive **Bottom Line Positive dipstick + symptoms: – consider treatment (and culture) Negative dipstick + symptoms: – consider culture When do you need radiologic imagining or further evaluation for diagnosis of UTI? Generally, uncomplicated cystitis or pyelonephritis does not benefit from imaging Consider CT, ultrasound, voiding cystourethrogram (VCUG) and cystoscopic or ureteroscopic evaluation for patients with *known anatomic abnormality *those who do not respond to treatment Pathogenesis of urinary tract infections Ascending infection from periurethral area critical Hematogenous spread is uncommon Risk factors Reduced urine flow Obstruction, stricture, neurogenic bladder Factors that promote colonization Sexual activity, spermacide, estrogen depletion Facilitation of ascent Catheterization, incontinence, residual urine What bacteria are associated with urinary infections and what pathogenic factors from both bacteria and the host contribute to colonization? Uropathogens Escherichia coli (80% of outpatient UTIs) Klebsiella Enterobacter Proteus Pseudomonas Staphylococcus saprophyticus (5-15%) Enterococcus Candida Adenovirus Normal perineal flora: Lactobacillus, Corynebacteria, Staphylococcus, Streptococcus, anaerobes -The bladder mucosal surface has antibacterial properties that eliminate some organisms, presumably through mucus trapping and a polymorphonuclear leukocyte response. -In addition, urine that has a low pH, high or very low osmolarity, high urea concentration, or high organic acid content inhibits bacterial growth -Abnormal micturition, a significant residual urine volume, or both will promote true infection. -There are also acquired and intrinsic host factors, as well as bacterial virulence factors, which increase the likelihood of development of UTI. What are some correctable Urologic abnormalities that may provoke bacterial persistence? Bacterial persistence Infected stones Fistula disease (colovesical, vesicovaginal) Unilateral infected atrophic kidneys Ureteral duplication and ectopic ureters Foreign bodies (such as retained ureteral stent) Urethral diverticula Unilateral medullary sponge kidneys Infected ureteral stump after nephrectomy Infected urachal or renal cyst Papillary necrosis Medullary sponge kidneys Kidney stones Patient found on exam to have poor water intake, atrophic vaginitis, and urine dipstick consistent with acute bacterial infection. What are the treatment options? Treatment Encourage hydration and behavioral measures to increase fluid intake Treat atrophic vaginitis with topical transvaginal estrogen if appropriate Determine if infection represents uncomplicated or complicated infection Uncomplicated UTI treatment 3 day course of trimethoprim/sulfamethoxazole (TMP/SMX) For local TMP/SMX resistance pattern > 20% , consider fluoroquinolones Full 7 day course in patients with diabetes, long duration of symptoms, pregnancy, > 65 years old, past history of pyelonephritis Complicated UTI treatment Culture essential Ampicillin + aminoglycoside Amp/Vancomycin + aminoglycoside or 3rd generation cephalosporin Adjust according to culture results If good clinical response, switch to oral agents in 48 hours Treat for 14 days Follow-up and general rules of thumb Test for cure by repeat culture for pregnancy, pyelonephritis, and complicated or relapsing UTI Consider single dose post-coital self-treatment in select cases Do not treat asymptomatic bacteruria Treatment often not indicated for patients on self catheterization protocols Urinary Incontinence Bladder dysfunction Urethral dysfunction Bladder dysfunction Urge incontinence detrusor overactivity detrusor overactivity of nonneurogenic origin detrusor overactivity of neurogenic origin poor compliance Overflow incontinence Urethral dysfunction Stress incontinence anatomic ( due to mobility of the bladder neck) Intrinsic sphincter deficiency (due to bladder neck dysfunction) Transient Causes of Incontinence Cause Comment Delirium Incontinence may be secondary to delirium and will often stop when acute delirium resolves. Infection Symptomatic infection may increase urinary tract irritation and resulting incontinence Atrophic vaginitis Vaginitis may result in the same symptoms of an infection. Pharmacologic Sedatives Alcohol and long-acting benzodiazepines may cause confusion and secondary incontinence. Diuretics brisk diuresis may overwhelm the bladder's capacity and cause uninhibited detrusor contractions, resulting in urge incontinence. Anticholinergics Many nonprescription and prescription medications have anticholinergic properties. Side effects of anticholinergics include urinary retention with associated frequency and overflow incontinence. Alpha-adrenergics Tone in the bladder neck and proximal sphincter is increased by alpha adrenergic agonists and can manifest with urinary retention, particularly in men with prostatism. Alpha-antagonists Tone in the smooth muscles of the bladder neck and proximal sphincter is decreased with alpha adrenergic antagonists. Women treated with these drugs for hypertension may develop or have an exacerbation of stress incontinence. Psychological Depression may be occasionally associated with incontinence. Excessive urine production Excessive intake, diabetes, hypercalcemia, congestive heart failure and peripheral edema can all lead to polyuria, which can exacerbate incontinence. Restricted mobility Incontinence may be precipitated or aggravated if the patient is unable to toilet in a timely fashion. Stool impaction Patients with impacted stool can have urge or overflow urinary incontinence and may also have concomitant fecal incontinence. Bladder dysfunction Storage Emptying Urge incontinence occurs when the bladder pressure is sufficient to overcome the sphincter mechanism. The sphincter is programmed to open during periods of elevated detrusor pressure and this occurs during normal voiding. Elevation in detrusor pressure may occur from abnormal bladder contractions also known as detrusor overactivity. Elevation in pressures also occur in a poorly compliant bladder. Detrusor overactivity with UUI Idiopathic Neurologic disease (detrusor overactivity of neurogenic origin) Detrusor overactivity is exceedingly common in the elderly and may be associated with bladder outlet obstruction Poor bladder compliance results from loss of the visicoelastic features of the bladder or because of a change in neural-regulatory activity Patients with urgency incontinence may appreciate a sudden sensation to void which is difficult to defer. Urge incontinence The patient may not be aware of the sensation of needing to void until they are actually leaking. The amount of leakage in patients with urgency incontinence is variable, depending on the patient's ability to suppress the contraction and the strength of their outlet. Patients with urgency incontinence will often manifest frequency, nocturia, and occasionally nocturnal enuresis. Overactive bladder has become the popularized term for describing patients with frequency and urgency with or without urgency incontinence. Overflow incontinence Occurs at extreme bladder volumes or when the bladder volume reaches the limit of the urethral mechanism or the bladder's viscoelastic properties The loss of urine is driven by an elevation in detrusor pressure which overcomes the outlet resistance Overflow incontinence is seen with incomplete bladder emptying caused either by obstruction or poor bladder contractility Obstruction is rare in women but can result from severe pelvic prolapse or following surgery for stress incontinence Patients with overflow incontinence will complain of constant dribbling and
Recommended publications
  • Urinary Incontinence: Impact on Long Term Care
    Urinary Incontinence: Impact on Long Term Care Muhammad S. Choudhury, MD, FACS Professor and Chairman Department of Urology New York Medical College Director of Urology Westchester Medical Center 1 Urinary Incontinence: Overview • Definition • Scope • Anatomy and Physiology of Micturition • Types • Diagnosis • Management • Impact on Long Term Care 2 Urinary Incontinence: Definition • Involuntary leakage of urine which is personally and socially unacceptable to an individual. • It is a multifactorial syndrome caused by a combination of: • Genito urinary pathology. • Age related changes. • Comorbid conditions that impair normal micturition. • Loss of functional ability to toilet oneself. 3 Urinary Incontinence: Scope • Prevalence of Urinary incontinence increase with age. • Affects more women than men (2:1) up to age 80. • After age 80, both women and men are equally affected. • Urinary Incontinence affect 15% to 30% of the general population > 65 years. • > 50% of 1.5 million Long Term Care residents may be incontinent. • The cost to care for this group is >5 billion per year. • The total cost of care for Urinary Incontinence in the U.S. is estimated to be over $36 billion. Ehtman et al., 2012. 4 Urinary Incontinence: Impact on Quality of Life • Loss of self esteem. • Avoidance of social activity and interaction. • Decreased ability to maintain independent life style. • Increased dependence on care givers. • One of the most common reason for long term care placement. Grindley et al. Age Aging. 1998; 22: 82-89/Harris T. Aging in the eighties. NCHS # 121 1985. Noelker L. Gerontologist 1987; 27: 194-200. 5 Health related consequences of Urinary Incontinence • Increased propensity for fall/fracture.
    [Show full text]
  • CMS Manual System Human Services (DHHS) Pub
    Department of Health & CMS Manual System Human Services (DHHS) Pub. 100-07 State Operations Centers for Medicare & Provider Certification Medicaid Services (CMS) Transmittal 8 Date: JUNE 28, 2005 NOTE: Transmittal 7, of the State Operations Manual, Pub. 100-07 dated June 27, 2005, has been rescinded and replaced with Transmittal 8, dated June 28, 2005. The word “wound” was misspelled in the Interpretive Guidance section. All other material in this instruction remains the same. SUBJECT: Revision of Appendix PP – Section 483.25(d) – Urinary Incontinence, Tags F315 and F316 I. SUMMARY OF CHANGES: Current Guidance to Surveyors is entirely replaced by the attached revision. The two tags are being combined as one, which will become F315. Tag F316 will be deleted. The regulatory text for both tags will be combined, followed by this revised guidance. NEW/REVISED MATERIAL - EFFECTIVE DATE*: June 28, 2005 IMPLEMENTATION DATE: June 28, 2005 Disclaimer for manual changes only: The revision date and transmittal number apply to the red italicized material only. Any other material was previously published and remains unchanged. However, if this revision contains a table of contents, you will receive the new/revised information only, and not the entire table of contents. II. CHANGES IN MANUAL INSTRUCTIONS: (N/A if manual not updated.) (R = REVISED, N = NEW, D = DELETED) – (Only One Per Row.) R/N/D CHAPTER/SECTION/SUBSECTION/TITLE R Appendix PP/Tag F315/Guidance to Surveyors – Urinary Incontinence D Appendix PP/Tag F316/Urinary Incontinence III. FUNDING: Medicare contractors shall implement these instructions within their current operating budgets. IV. ATTACHMENTS: Business Requirements x Manual Instruction Confidential Requirements One-Time Notification Recurring Update Notification *Unless otherwise specified, the effective date is the date of service.
    [Show full text]
  • 3-Year Results of Transvaginal Cystocele Repair with Transobturator Four-Arm Mesh: a Prospective Study of 105 Patients
    Arab Journal of Urology (2014) 12, 275–284 Arab Journal of Urology (Official Journal of the Arab Association of Urology) www.sciencedirect.com ORIGINAL ARTICLE 3-year results of transvaginal cystocele repair with transobturator four-arm mesh: A prospective study of 105 patients Moez Kdous *, Fethi Zhioua Department of Obstetrics and Gynecology, Aziza Othmana Hospital, Tunis, Tunisia Received 27 January 2014, Received in revised form 1 May 2014, Accepted 24 September 2014 Available online 11 November 2014 KEYWORDS Abstract Objectives: To evaluate the long-term efficacy and safety of transobtura- tor four-arm mesh for treating cystoceles. Genital prolapse; Patients and methods: In this prospective study, 105 patients had a cystocele cor- Cystocele; rected between January 2004 and December 2008. All patients had a symptomatic Transvaginal mesh; cystocele of stage P2 according to the Baden–Walker halfway stratification. We Polypropylene mesh used only the transobturator four-arm mesh kit (SurgimeshÒ, Aspide Medical, France). All surgical procedures were carried out by the same experienced surgeon. ABBREVIATIONS The patients’ characteristics and surgical variables were recorded prospectively. The VAS, visual analogue anatomical outcome, as measured by a physical examination and postoperative scale; stratification of prolapse, and functional outcome, as assessed by a questionnaire TOT, transobturator derived from the French equivalents of the Pelvic Floor Distress Inventory, Pelvic tape; Floor Impact Questionnaire and the Pelvic Organ Prolapse–Urinary Incontinence- TVT, tension-free Sexual Questionnaire, were considered as the primary outcome measures. Peri- vaginal tape; and postoperative complications constituted the secondary outcome measures. TAPF, tendinous arch Results: At 36 months after surgery the anatomical success rate (stage 0 or 1) was of the pelvic fascia; 93%.
    [Show full text]
  • Managing Female Urethral Diverticulum with a Standardized Technique Using a Pacifier-Trick Artifice to Facilitate Dissection
    International Urogynecology Journal (2019) 30:789–794 https://doi.org/10.1007/s00192-018-3754-8 ORIGINAL ARTICLE Managing female urethral diverticulum with a standardized technique using a pacifier-trick artifice to facilitate dissection Philippe Neveü1 & Idir Ouzaid1 & Evanguelos Xylinas1 & Christophe Egrot1 & Vincent Ravery1 & Jean-François Hermieu1 Received: 21 February 2018 /Accepted: 12 August 2018 /Published online: 3 September 2018 # The International Urogynecological Association 2018 Abstract Introduction and hypothesis Managing urethral diverticula is challenging because of recurrence rate and postoperative compli- cations. Herein, we report a standardized, single-institution experience of surgical treatment of urethral diverticula in women. Methods The medical record of 37 female patients treated for urethral diverticula between 2005 and 2017 in a single institution were reviewed. All patients were operated in a standardized genupectoral position using a technical artifice called the pacifier trick to inflate diverticula throughout the procedure and facilitate its dissection. Symptoms at diagnosis, imaging findings, surgical parameters, postoperative complications, and recurrence rates were collected and are presented. Results Median age was 39 ± 11 (range 21–67) years. At diagnosis, recurrent urinary tract infections (UTI) (67%), vaginal mass (46%), pelvic pain (43%), dyspareunia (27%), and urinary incontinence (UI) (24%) were the most commonly reported symp- toms. Median operative time was 98 ± 31 (range 40–150) min. After a mean follow-up of 1 year, recurrence occurred in one (3%) patient. Immediate de novo postoperative UI decreased from 27% immediately after surgery to 3% after pelvic physical therapy. Pathological analyses found no malignant histology. Conclusions Surgical management of urethral diverticula in women is technically demanding.
    [Show full text]
  • Complications of Incontinence and Prolapse Surgery: Evaluation, Intervention, and Resolution—A Review from Both Specialties W42, 16 October 2012 14:00 - 18:00
    Complications of Incontinence and Prolapse Surgery: Evaluation, Intervention, and Resolution—A Review from Both Specialties W42, 16 October 2012 14:00 - 18:00 Start End Topic Speakers 14:00 14:10 Introduction Howard Goldman 14:10 14:35 Complications of incontinence surgery (except Sandip Vasavada retention) 14:35 15:10 Retention/Voiding dysfunction after incontinence Roger Dmochowski surgery 15:10 15:30 Discussion All 15:30 16:00 Break None 16:00 16:35 Complications of prolapse surgery (except Howard Goldman dyspareunia) 16:35 17:00 Dyspareunia after pelvic floor surgery Tristi Muir 17:00 17:40 Discussion All 17:40 18:00 Questions All Aims of course/workshop This course will summarize both common and uncommon complications associated with standard and new technologies used for pelvic floor reconstruction and urinary incontinence therapy in women. The intent of this course is to present both the approach to evaluation and management of these complications from both the urologic and urogynecologic perspective of the combined faculty. The emphasis is on newer technologies and complications, both acute and chronic, which are associated with these various surgeries. The goal of this course will be to summarize, not only identification, but also evaluation and appropriate intervention, as well as patient counselling for these various complications. Educational Objectives This course will provide a detailed paradigm for avoiding, evaluating and managing complications of incontinence and prolapse surgery. Evidence continues to accrue in this area but it runs the spectrum from Level 1 to 5 with much being expert opinion. Unfortunately, very little cross comparison exists to support these differing interventions.
    [Show full text]
  • Pessary Information
    est Ridge obstetrics & gynecology, LLP 3101 West Ridge Road, Rochester, NY 14626 1682 Empire Boulevard, Webster, NY 14580 www.wrog.org Tel. (585) 225‐1580 Fax (585) 225‐2040 Tel. (585) 671‐6790 Fax (585) 671‐1931 USE OF THE PESSARY The pessary is one of the oldest medical devices available. Pessaries remain a useful device for the nonsurgical treatment of a number of gynecologic conditions including pelvic prolapse and stress urinary incontinence. Pelvic Support Defects The pelvic organs including the bladder, uterus, and rectum are held in place by several layers of muscles and strong tissues. Weaknesses in this tissue can lead to pelvic support defects, or prolapse. Multiple vaginal deliveries can weaken the tissues of the pelvic floor. Weakness of the pelvic floor is also more likely in women who have had a hysterectomy or other pelvic surgery, or in women who have conditions that involve repetitive bearing down, such as chronic constipation, chronic coughing or repetitive heavy lifting. Although surgical repair of certain pelvic support defects offers a more permanent solution, some patients may elect to use a pessary as a very reasonable treatment option. Classification of Uterine Prolapse: Uterine prolapse is classified by degree. In first‐degree uterine prolapse, the cervix drops to just above the opening of the vagina. In third‐degree prolapse, or procidentia, the entire uterus is outside of the vaginal opening. Uterine prolapse can be associated with incontinence. Types of Vaginal Prolapse: . Cystocele ‐ refers to the bladder falling down . Rectocele ‐ refers to the rectum falling down . Enterocele ‐ refers to the small intestines falling down .
    [Show full text]
  • Legacy Health
    Legacy Health Co-Management and Referral Guidelines Management of Pelvic Floor Dysfunction Phone: 503-413-3707 Legacy Physical Therapy Fax: 503-413-1504 Introduction After appropriate evaluation by your care providers, patients may be referred to pelvic floor physical therapy for management of pelvic floor muscle dysfunctions/pain, incontinence of urine or fecal matter, pelvic floor/girdle physical therapy. • Hypertonic pelvic floor dysfunction — vaginismus, dyspareunia, levator ani syndrome • Hypotonic pelvic floor muscles — organ prolapse, rectus diastasis • Continence issues after abdominal surgeries in male and female (prostate or hysterectomies), overactive bladder • Endometriosis, pelvic pain • Chronic constipation Evaluation Evaluation and A careful history and evaluation/physical exam will be performed to assess the origin and functional Management limitations of the patient. Muscle tone assessment, organ mobility, scar tissue mobility, bladder and/or bowel diary Treatment Strengthening or down-training PF muscles, with or without biofeedback, manual therapy, scar tissue release, electrical stimulation, trigger point release, visceral and myofascial mobilization, body mechanics and core stabilization. Duration One to six 60-minute visits with the physical therapist When to refer Refer when pain is limiting normal activities of daily living, if patient is not able to get to the bathroom dry, if sexual activity is painful (although dyspareunia alone is often not covered by insurance) Commonly referred ICD10 codes and descriptors for PT diagnoses R10.9 Abdominal pain K59.4 Anal spasm/proctalgia fugax R39.89 Bladder pain M53.3 Coccygodynia K59.00 Constipation, unspecified N81.10 Cystocele, unspecified (prolapse of anterior vaginal wall NOS) M62.0 Diastasis rectus post-partum N94.1 Dyspareunia — excludes psychogenic dyspareunia (F52.6).
    [Show full text]
  • Pelvic Floor Ultrasound in Prolapse: What's in It for the Surgeon?
    Int Urogynecol J (2011) 22:1221–1232 DOI 10.1007/s00192-011-1459-3 REVIEW ARTICLE Pelvic floor ultrasound in prolapse: what’s in it for the surgeon? Hans Peter Dietz Received: 1 March 2011 /Accepted: 10 May 2011 /Published online: 9 June 2011 # The International Urogynecological Association 2011 Abstract Pelvic reconstructive surgeons have suspected technique became an obvious alternative, whether via the for over a century that childbirth-related trauma plays a transperineal [4, 5] (see Fig. 1) or the vaginal route [6]. major role in the aetiology of female pelvic organ prolapse. More recently, magnetic resonance imaging has also Modern imaging has recently allowed us to define and developed as an option [7], although the difficulty of reliably diagnose some of this trauma. As a result, imaging obtaining functional information, and cost and access is becoming increasingly important, since it allows us to problems, have hampered its general acceptance. identify patients at high risk of recurrence, and to define Clinical examination techniques, in particular if the underlying problems rather than just surface anatomy. examiner is insufficiently aware of their inherent short- Ultrasound is the most appropriate form of imaging in comings, are rather inadequate tools with which to assess urogynecology for reasons of cost, access and performance, pelvic floor function and anatomy. This is true even if one and due to the fact that it provides information in real time. uses the most sophisticated system currently available, the I will outline the main uses of this technology in pelvic prolapse quantification system of the International Conti- reconstructive surgery and focus on areas in which the nence Society (ICS Pelvic Organ Prolapse Quantification benefit to patients and clinicians is most evident.
    [Show full text]
  • The Effects of a Life-Stress Interview for Women with Chronic Urogenital Pain: a Randomized Trial" (2016)
    Wayne State University Wayne State University Dissertations 1-1-2016 The ffecE ts Of A Life-Stress Interview For Women With Chronic Urogenital Pain: A Randomized Trial Jennifer Carty Wayne State University, Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations Part of the Clinical Psychology Commons Recommended Citation Carty, Jennifer, "The Effects Of A Life-Stress Interview For Women With Chronic Urogenital Pain: A Randomized Trial" (2016). Wayne State University Dissertations. Paper 1521. This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState. THE EFFECTS OF A LIFE-STRESS INTERVIEW FOR WOMEN WITH CHORNIC UROGENITAL PAIN: A RANDOMIZED TRAIL by JENNIFER N. CARTY DISSERTATION Submitted to the Graduate School of Wayne State University, Detroit, Michigan in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY 2016 MAJOR: PSYCHOLOGY (Clinical) Approved By: ______________________________ Advisor Date ______________________________ ______________________________ ______________________________ ACKNOWLEDGEMENTS I am immensely grateful to many people for their contributions to this project and my professional and personal development. First, I would like to thank my advisor, Dr. Mark Lumley, for his guidance and support in the development of this project, and for both encouraging and challenging me throughout my academic career, for which I will always be grateful. I would also like to thank Dr. Janice Tomakowsky, Dr. Kenneth Peters, and the medical providers, physical therapists, and staff at the Women’s Urology Center at Beaumont Hospital for graciously allowing me to conduct this study at their clinic and with their patients.
    [Show full text]
  • Urinary Retention in Women Workshop Chair: David Castro-Diaz, Spain 07 October 2015 08:30 - 11:30
    W16: Urinary Retention in Women Workshop Chair: David Castro-Diaz, Spain 07 October 2015 08:30 - 11:30 Start End Topic Speakers 08:30 08:45 Urinary retention in women: concepts and pathophysiology David Castro-Diaz 08:45 08:50 Discussion All 08:50 09:05 Evaluation Tufan Tarcan 09:05 09:10 Discussion All 09:10 09:30 Conservative management Cristina Naranjo-Ortiz 09:30 09:35 Discussion All 09:35 09:55 Medical and surgical management Christopher Chapple 09:55 10:00 Discussion All 10:00 10:30 Break None 10:30 11:20 Typical clinical cases discussion All 11:20 11:30 Take home messages David Castro-Diaz Aims of course/workshop Urinary retention in women is rare and diverse. Diagnostic criteria are not agreed and epidemiology is not well known. Forms of urinary retention in women include: complete retention, incomplete or insufficient emptying and elevated post-void residual. It may be acute or chronic, symptomatic or asymptomatic. Etiology is multifactorial including anatomic or functional bladder outlet obstruction and bladder dysfunction related to neurological diseases, diabetes mellitus, aging, pharmacotherapy, pain and infective/inflammatory disease and idiopathic or unknown aetiology. This workshop will analyse and discuss physiopathology, evaluation and management of urinary retention in women from an integral, practical and evidence based approach. Learning Objectives 1. Identify urinary retention in women, its etiology and risk factors. 2. Carry out proper diagnosis of urinary retention in women as well as its relationship with risk and influent factors. 3. Properly manage female acute and chronic acute and chronic urinary retention with the different approaches including conservative, medical and surgical therapies.
    [Show full text]
  • What I Need to Know About Bladder Control for Women
    What I need to know about BladderBladder ControlControl forfor WomenWomen U.S. Department NATIONAL INSTITUTES OF HEALTH of Health and National Kidney and Urologic Diseases Information Clearinghouse Human Services What I need to know about Bladder Control for Women NATIONAL INSTITUTES OF HEALTH National Diabetes Information Clearinghouse Contents Urine Leakage: A Common Health Problem for Women of All Ages ................................................................ 1 How does the bladder work?................................................. 2 What are the different types of bladder control problems? ................................................................................ 5 What causes bladder control problems? .............................. 7 How do I tell my health care team about my urine leakage?................................................................................... 9 How is loss of bladder control treated?.............................. 11 Hope Through Research...................................................... 17 For More Information.......................................................... 18 Acknowledgments................................................................. 19 *Inserts in back pocket A. What Your Doctor Needs to Know B. Your Daily Bladder Diary C. Kegel Exercise Tips D. Medicines for Bladder Control Urine Leakage: A Common Health Problem for Women of All Ages You may think bladder control problems are something that happen when you get older. The truth is that women of all ages have urine
    [Show full text]
  • Nerve Disease and Bladder Control
    Nerve Disease and Bladder Control National Kidney and Urologic Diseases Information Clearinghouse For the urinary system to do its job, muscles and nerves must work together to hold Brain urine in the bladder and then release it at the right time. Nerves carry messages from NATIONAL the bladder to the brain to let it know when INSTITUTES the bladder is full. They also carry messages OF HEALTH Central nervous from the brain to the bladder, telling muscles system (brain either to tighten or release. A nerve prob­ and spinal cord) lem might affect your bladder control if the nerves that are supposed to carry messages Spinal cord between the brain and the bladder do not work properly. Nerve signals U.S. Department to bladder of Health and Bladder and sphincter Human Services What bladder control muscles problems does nerve damage cause? Nerves that work poorly can lead to three Urethra different kinds of bladder control problems. Overactive bladder. Damaged nerves may Sphincter muscles send signals to the bladder at the wrong time, causing its muscles to squeeze with­ Nerves carry signals from the brain to the bladder out warning. The symptoms of overactive and sphincter. bladder include • urinary frequency—defined as urination eight or more times a day or two or nerves to the sphincter muscles are dam­ more times at night aged, the muscles may become loose and allow leakage or stay tight when you are • urinary urgency—the sudden, strong trying to release urine. need to urinate immediately Urine retention. For some people, nerve • urge incontinence—leakage of urine damage means their bladder muscles do that follows a sudden, strong urge to not get the message that it is time to release urinate urine or are too weak to completely empty Poor control of sphincter muscles.
    [Show full text]